Back to top

Evidence summary BITE 20 – Cardiovascular disease and smoking cessation

Who needs to know?

Primary Care, Diabetes and Cardiology Specialist Teams

What have we found?

Our findings suggests that, in people with Type 2 diabetes, concurrent treatment with metformin attenuates the observed higher cardiovascular and mortality risk in ex- and current smokers.

In addition to smoking cessation support, treatment with metformin, particularly in ex- and current smokers, should be encouraged.